Reta glucagon-like peptide-1 (GLP-1) receptor agonists offer a groundbreaking strategy to diabetes management. These innovative therapies operate by mimicking the physiological actions of GLP-1, a hormone secreted by https://ianxjgn222996.prublogger.com/profile